• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    Gilead Sciences Inc. (GILD)

    -NasdaqGS
    111.71 Up 0.49(0.44%) May 22, 4:00PM EDT
    |After Hours : 111.70 Down 0.01 (0.01%) May 22, 7:55PM EDT
    Add to Portfolio
    Prev Close:111.22
    Open:110.95
    Bid:111.50 x 200
    Ask:111.76 x 700
    1y Target Est:121.22
    Beta:0.93
    Earnings Date:Jul 21 - Jul 27 (Est.)
    Day's Range:110.70 - 112.66
    52wk Range:78.50 - 116.83
    Volume:12,079,030
    Avg Vol (3m):10,767,600
    Market Cap:165.00B
    P/E (ttm):12.74
    EPS (ttm):8.77
    Div & Yield:1.72 (1.70%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    GILDUp 0.44%165.00B
    GSKDown 0.66%109.30B
    PFEDown 0.23%211.08B
    RHHBYDown 0.94%N/A

    Key Statistics

    Forward P/E (1 yr):10.14
    P/S (ttm):5.95
    Ex-Dividend Date:12-Jun-15

    Analysts

    Annual EPS Est (Dec-15) :10.86
    Quarterly EPS Est (Jun-15) :2.66
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):0.77

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical nee in North America, South America, Europe, and the Asia-Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback